Pharmacovigilance Market SWOT Analysis by 2031
L'augmentation des cas d'effets indésirables des médicaments et l'augmentation de la consommation de médicaments à travers le monde devraient alimenter la croissance de la pharmacovigilance. marché au cours de la période de prévision. De plus, l'évolution de l'externalisation de diverses activités dans le secteur pharmaceutique et des sciences de la vie devrait offrir des opportunités de croissance significatives sur le marché.
L'analyse du marché mondial de la pharmacovigilance jusqu'en 2031 est une étude spécialisée et approfondie. du secteur informatique de la santé en mettant l’accent sur la tendance du marché mondial. Le rapport vise à fournir un aperçu du marché mondial avec une segmentation détaillée du marché par phase d’essai clinique, fournisseur de services, type de méthode, utilisateur final et géographie. Le marché mondial devrait connaître une forte croissance au cours de la période de prévision. Le rapport fournit des statistiques clés sur l'état du marché des principaux acteurs du marché de la pharmacovigilance et présente les principales tendances et opportunités du marché.
Le marché mondial de la pharmacovigilance est segmenté en fonction de la phase d'essai clinique, du fournisseur de services, type de méthode et utilisateur final. Sur la base de la phase des essais cliniques, le marché est classé en préclinique, phase I, phase II, phase III et phase IV. De même, sur la base du type de service, le marché est classé en sous-traitance interne et sous contrat. Le marché de la pharmacovigilance est segmenté en fonction du type de méthode telle que la déclaration spontanée, la déclaration intensifiée des effets indésirables, la déclaration spontanée ciblée, la surveillance des événements de cohorte et l’exploration du DSE. Sur la base de l’utilisateur final, le marché est classé en hôpitaux, organismes de recherche et industriels.
Le rapport fournit un aperçu détaillé du secteur, comprenant des informations qualitatives et quantitatives. Il fournit un aperçu et des prévisions de la phase d’essai clinique, du fournisseur de services, du type de méthode et de l’utilisateur final du marché mondial de la pharmacovigilance. Il fournit également la taille et les prévisions du marché jusqu’en 2031 pour le marché global dans cinq grandes régions, à savoir : Amérique du Nord, Europe, Asie-Pacifique (APAC), Moyen-Orient et Afrique (MEA) et Amérique du Sud et du Sud. Amérique centrale. Le marché de la pharmacovigilance de chaque région est ensuite sous-segmenté par pays et segments respectifs. Le rapport couvre l'analyse et les prévisions de 18 pays dans le monde ainsi que les tendances actuelles et les opportunités prévalant dans la région.
L'Amérique du Nord devrait contribuer à la plus grande part du marché de la pharmacovigilance dans les années à venir, en raison de la présence d'importants acteurs du marché de la région ainsi que les initiatives visant à réduire les dépenses de santé ainsi que les infrastructures de santé sophistiquées. L’Asie-Pacifique devrait connaître une croissance significative du marché au cours de la période de prévision, en raison de l’adoption croissante de l’informatique dans le domaine de la santé et de l’offre de meilleurs services aux patients.
Le rapport analyse les facteurs affectant le marché de la pharmacovigilance. du côté de la demande et de l’offre et évalue plus en détail la dynamique du marché affectant le marché au cours de la période de prévision, c’est-à-dire les moteurs, les contraintes, les opportunités et les tendances futures. Le rapport fournit également une analyse PEST exhaustive pour les cinq régions, à savoir : Amérique du Nord, Europe, APAC, MEA et Amérique du Sud et du Sud. Amérique centrale après avoir évalué les facteurs politiques, économiques, sociaux et technologiques affectant le marché de la pharmacovigilance dans ces régions.
Le rapport comprend également les profils des principales sociétés de pharmacovigilance ainsi que leur analyse SWOT et leurs stratégies de marché. En outre, le rapport se concentre sur les principaux acteurs de l’industrie avec des informations telles que les profils d’entreprise, les composants et services proposés, les informations financières des 3 dernières années et les développements clés des cinq dernières années. Certains des principaux acteurs opérant sur le marché de la pharmacovigilance comprennent Accenture, Bristol-Myers Squibb Company, Linical Accelovance, Cognizant, Covance Inc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc., ICON plc, Capgemini (IGATE Corporation). , et Novartis AG, entre autres.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. Accenture
2. Bristol-Myers Squibb Company
3. Linical Accelovance
4. Cognizant
5. Covance Inc.
6. F. Hoffmann-La Roche Ltd.
7. GlaxoSmithKline plc.
8. ICON plc
9. Capgemini (IGATE Corporation)
10. Novartis AG
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For